About the Program
The One-Day Seminar on Therapeutic Innovations, Intellectual Property Dynamics, and the Future of Pharmaceuticals is designed to bring together researchers, academicians, industry experts, and students to explore cutting-edge advancements in drug discovery and therapeutic approaches. The program will highlight the critical role of intellectual property in safeguarding innovations while fostering a discussion on emerging trends shaping the future of the pharmaceutical industry.
Objectives of the Program
- To provide participants with insights into recent advancements in therapeutic innovations and their implications for the future of the pharmaceutical industry.
- To create awareness about intellectual property rights, patent filing strategies, and their role in safeguarding and translating pharmaceutical innovations.
Expected outcomes of the programme
- Participants will develop an understanding of emerging therapeutic innovations and their role in shaping the future pharmaceutical industry.
- Attendees will gain knowledge of patent drafting, filing, and strategies for translating research into innovations.
Committee Members
- Dr. Manjunatha P M, Professor & Principal, ABMRCP
- Dr. Hiriyanna Ganesh Bhat, Professor, Dept. of Pharmaceutical Quality Assurance
- Dr. K.Selvakumar, Associate Professor & HoD, Dept. of Pharmaceutical Quality Assurance, ABMRCP
- Dr. Gurubasavaraja Swamy PM, Professor & HoD, Dept. of Pharmaceutical Chemistry, ABMRCP
- Dr. Rajesh R, Professor & HoD, Dept. of Pharmaceutical Analysis
- Mr. Abhishek Ghara, Assistant Professor, Dept. of Pharmaceutical Chemistry
Resource Persons Details
Dr. Ravindra Vikram Singh
Designation: Director and Head,
India R & D,
Sigma-Aldrich (Merck KGaK)
Dr. Gyanveer Singh
Designation: Founding Partner, LexAnalytico Consulting